Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scheer & Company is a private life sciences advisory and venture capital firm founded in 1981 and led by David I. Scheer. The firm focuses on corporate strategy, transactional advisory, company building, and venture-related activities for clients and entrepreneurial partners in the life sciences sector. Rather than operating as a drug developer with its own disclosed therapeutic pipeline, Scheer & Company appears to function primarily as a strategic advisor and investment-oriented company builder. Its profile is closely tied to David Scheer’s long-standing role in forming, advising, and chairing multiple biotech and healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scheer & Company.